Tuesday, April 14, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

Almonty Industries: A $5.8 Billion Bet on American Wolfram

Rodolfo Hanigan by Rodolfo Hanigan
April 14, 2026
in Commodities, Industrial, Mergers & Acquisitions, Nasdaq, Turnaround
0
Almonty Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

The strategic metal wolfram, better known as tungsten, is at the heart of a dramatic corporate relocation. Almonty Industries Inc., a key player in the sector, has officially moved its corporate headquarters from Toronto, Canada, to Dillon, Montana. This is far more than a change of address; it’s a calculated pivot designed to embed the company directly into the U.S. national security and defense industrial base. The market’s immediate reaction was a powerful endorsement, with shares surging 15.3 percent to $20.62 on April 13.

This relocation is the culmination of a broader strategic shift that investors have been rewarding for months. On its home Canadian exchange, the stock closed at 28.42 CAD recently, marking a staggering 676 percent gain over the past twelve months. The company’s current market capitalization stands at approximately $5.82 billion.

Financing this ambitious transition required significant capital, which Almonty secured in two major moves. First was an oversubscribed initial public offering on the NASDAQ in July 2025, which raised $90 million. This was followed by a subsequent financing round in December 2025 that brought in an additional $129.4 million.

Operationally, Almonty’s growth rests on two distinct geographic pillars. In South Korea, the company has completed Phase 1 construction at its flagship Sangdong mine. This asset is projected to eventually supply around 40 percent of the global demand for tungsten outside of China. Concurrently, the focus in the United States is on the recently acquired Vantage (formerly Gentung) tungsten project in Montana. Production at this site is slated to commence later in 2026.

Should investors sell immediately? Or is it worth buying Almonty?

The move to Montana is explicitly designed to forge closer ties with U.S. government agencies and defense contractors. To facilitate this, Almonty has bolstered its leadership team with figures possessing deep Pentagon connections. Retired Brigadier General Steven L. Allen has been appointed Chief Operating Officer, a role intended to streamline access to U.S. Department of Defense procurement processes. The company is also working with the consulting firm American Defense International to navigate the Washington landscape.

Wall Street analysts are taking note of this strategic repositioning. Several firms have issued bullish ratings for the NASDAQ-listed shares. DA Davidson initiated coverage with a “Buy” rating and a $25 price target, while B. Riley Financial also recommends “Buy” with a $23 target. Oppenheimer is similarly positive, issuing an “Outperform” rating and a $19 target. Not all voices are uniformly optimistic, however, as evidenced by a current “Sell” recommendation from Weiss Ratings.

For its 2025 fiscal year, Almonty reported a net loss, largely attributed to non-cash revaluations of derivative liabilities. Yet the market’s substantial vote of confidence suggests investors are looking beyond the current income statement. They are betting on the company’s potential to become a primary, non-Chinese supplier of a metal critical to defense, aerospace, and industrial manufacturing. The planned production start in Montana this year represents the next concrete test of whether this high-stakes American strategy will deliver.

Ad

Almonty Stock: Buy or Sell?! New Almonty Analysis from April 14 delivers the answer:

The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 14.

Almonty: Buy or sell? Read more here...

Tags: Almonty
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

iShares Core MSCI World UCITS ETF USD (Acc) Stock
ETF

The $134 Billion ETF’s Tech-Heavy Crown Faces a Stress Test

April 13, 2026
BayWa Stock
Analysis

BayWa’s Creditor Standoff and Asset Sale Saga Define Pivotal Year

April 13, 2026
Replimune Stock
Analysis

Replimune’s Lead Drug Hits Second FDA Wall, Triggering Survival Mode

April 13, 2026

Recommended

Finance_Assets (2)

SunOpta Receives Buy Rating and Increased Price Target from Analysts

2 years ago
Moderna Stock

Moderna and BioNTech: Divergent Paths in the Post-Pandemic Era

2 months ago
Global Atomic Stock

Global Atomic Accelerates Construction at Flagship Uranium Mine

2 weeks ago
Lululemon Stock

Lululemon Stock: Navigating Recovery and Persistent Headwinds

8 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Goldman’s $17.2 Billion Quarter and the Brutal Sorting of Everything Else

BayWa’s Creditor Standoff and Asset Sale Saga Define Pivotal Year

Replimune’s Lead Drug Hits Second FDA Wall, Triggering Survival Mode

Red Cat’s Defense Tech Ecosystem Nears Critical Junctions

Eutelsat’s Launchpad: Balancing Explosive LEO Growth with Rocket Reliance

Hims & Hers: A Strategic Overhaul Tested by Margins and Market Sentiment

Trending

Almonty Stock
Commodities

Almonty Industries: A $5.8 Billion Bet on American Wolfram

by Rodolfo Hanigan
April 14, 2026
0

The strategic metal wolfram, better known as tungsten, is at the heart of a dramatic corporate relocation....

iShares Core MSCI World UCITS ETF USD (Acc) Stock

The $134 Billion ETF’s Tech-Heavy Crown Faces a Stress Test

April 13, 2026
Strategy Stock

Strategy’s $1 Billion Bitcoin Bet Defies Industry Exodus

April 13, 2026
Goldman's $17.2 Billion Quarter and the Brutal Sorting of Everything Else

Goldman’s $17.2 Billion Quarter and the Brutal Sorting of Everything Else

April 13, 2026
BayWa Stock

BayWa’s Creditor Standoff and Asset Sale Saga Define Pivotal Year

April 13, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Almonty Industries: A $5.8 Billion Bet on American Wolfram
  • The $134 Billion ETF’s Tech-Heavy Crown Faces a Stress Test
  • Strategy’s $1 Billion Bitcoin Bet Defies Industry Exodus

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com